Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

35.17
Delayed Data
As of Dec 08
 +0.33 / +0.95%
Today’s Change
34.52
Today|||52-Week Range
44.54
-8.67%
Year-to-Date
Puma (PBYI) Stock Up More than 200% This Year: Here's Why
Dec 08 / Zacks.com - Paid Partner Content
Glaxo Begins Phase III Study on Injection to Prevent HIV
Dec 01 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: FDA Nod for NVO's Ozempic, Second Indication for Lilly's Taltz
Dec 08 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Pfizer/Merck KGaA Drug Fails in Study, Teva CEO Announces Chang...
Dec 01 / Zacks.com - Paid Partner Content
GlaxoSmithKline and the Dividend Mirage
Dec 05 / GuruFocus News - Paid Partner Content
Glaxo Stock Down So Far This Year: Is a Reversal in Store?
Nov 30 / Zacks.com - Paid Partner Content
3 Drug/Biotech Stocks in Focus on World AIDS Day
Dec 01 / Zacks.com - Paid Partner Content
Glaxo Submits NDA for Anti Relapse Malaria Medicine to FDA
Nov 29 / Zacks.com - Paid Partner Content
Gilead & 3 Other Drug Stocks in Focus this World AIDS Day
Dec 01 / Zacks.com - Paid Partner Content
Glaxo, Pfizer's ViiV Healthcare Begins HIV Drug Combo Study
Nov 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close34.84
Today’s open34.94
Day’s range34.88 - 35.18
Volume4,530,512
Average volume (3 months)4,244,517
Market cap$86.5B
Dividend yield5.88%
Data as of 4:02pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+15.63%
Earnings growth (next 5 years)+4.05%
Revenue growth (last year)+2.85%
P/E ratio27.8
Price/Sales2.52
Price/Book61.63

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.58+0.94%
NVONovo Nordisk+0.61+1.18%
CELGCelgene+3.36+3.27%
ABTAbbott Laboratories-0.05-0.09%
Data as of 4:02pm ET, 12/08/2017

Financials

Next reporting dateFebruary 7, 2018
EPS forecast (this quarter)$0.69
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts